ASP Isotopes Inc. (JSE:ISO)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc | Market Cap | 15.87B +85.0% |
| Revenue (ttm) | 459.57M +511.2% |
| Net Income | -2.96B |
| EPS | -30.88 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 47,240 |
| Open | 12,347 |
| Previous Close | 12,248 |
| Day's Range | 11,980 - 12,600 |
| 52-Week Range | 6,710 - 150,000 |
| Beta | 3.27 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |
About ASP Isotopes
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages... [Read more]
Financial Performance
In 2025, ASP Isotopes's revenue was $23.85 million, an increase of 475.51% compared to the previous year's $4.14 million. Losses were -$175.09 million, 398.6% more than in 2024.
Financial numbers in USD Financial StatementsNews
ASP Isotopes restarted first 18 stages of Silicon-28 facility
ASP Isotopes (ASPI) announced that the Company has successfully restarted the first 18 stages of its Silicon-28 enrichment facility located in Pretoria, South Africa. “While the core enrichment techno...
ASP Isotopes Implements Engineering Enhancements to Silicon-28 Enrichment Facility; Successfully Restarts First 18 Stages of Silicon-28 Enrichment Facility; Commercial Shipments of Enriched Silicon-28 Expected to Commence in Q3 2026
ASP Isotopes has previously announced that it has signed three commercial contracts for the supply of enriched Silicon-28 to U.S.-based customers, and expects to make initial commercial shipments of e...
ASP Isotopes Quarterly report: Q1 2026
ASP Isotopes has published its Q1 2026 quarterly earnings report on May 20, 2026.
ASP Isotopes Slides: Corporate presentation
ASP Isotopes has posted slides in relation to its latest quarterly earnings report, which was published on May 12, 2026.
ASP Isotopes subsidiary enters into agreement for nuclear fuel supply
ASP Isotopes (ASPI) announced that Quantum Leap Energy, a wholly-owned subsidiary of ASP Isotopes, has entered into a non-binding memorandum of understanding with a European nuclear technology company...
Quantum Leap Energy Enters into Memorandum of Understanding with European Nuclear Technology Company for Advanced Nuclear Fuel Supply Collaboration
MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028 MOU establishes framework for collaboration with the goal to supply HAL...
Quantum Leap Energy Appoints Dr. Peter Fiske to Strategic Advisory Board
Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy Technology Commercialization Leader Expected to Enhance QLE's Government Partnersh...
ASP Isotopes Earnings Call Transcript: Q4 2025
Transitioning to commercial operations, revenue surged 480% in 2025, with major product launches and U.S. expansion planned for 2026. EBITDA is targeted to exceed $300 million by 2031, driven by strong demand in isotopes, helium, and electronic gases.
ASP Isotopes Earnings release: Q4 2025
ASP Isotopes released its Q4 2025 earnings on April 13, 2026, summarizing the period's financial results.
ASP Isotopes Annual report: Q4 2025
ASP Isotopes has published its Q4 2025 annual report on April 13, 2026.
ASP Isotopes Slides: Q4 2025
ASP Isotopes has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on April 13, 2026.
ASP Isotopes Inc. Provides Business Update
First Commercial Shipments Expected Across Multiple Isotopes in 2026 Expect to Obtain Helium Phase 1 Nameplate Capacity in Q3 2026 EBITDA Target of Greater Than $300 Million in 2031 Cash, Cash Equival...
ASP Isotopes Slides: Corporate presentation
ASP Isotopes has posted slides in relation to its latest quarterly earnings report, which was published on April 13, 2026.
ASP Isotopes to Host Business Update Conference Call on April 13, 2026, at 8:00 AM ET
DALLAS, April 10, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the pr...
Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
ASP Isotopes announces pact between Quantum Leap Energy, University of Bristol
ASP Isotopes (ASPI) announced that a UK subsidiary of Quantum Leap Energy, a wholly-owned subsidiary of ASPI, has commenced a strategic collaboration with the University of Bristol for the design…
ASP Isotopes Announces Strategic Collaboration Between Quantum Leap Energy and University of Bristol to Design Advanced Laser Research Facility
Collaboration to develop a cutting-edge lithium laser enrichment research facility in the UK Collaboration to develop a cutting-edge lithium laser enrichment research facility in the UK
ASP Isotopes Completes Well Drilling Required for Phase 1 of Renergen Helium Project Four Months Ahead of Schedule
DALLAS, March 23, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the pr...
ASP Isotopes Transcript: 2nd Annual CG Virtual Sustainability Summit
Helium supply disruptions are driving urgent expansion of South African production, with phase I ahead of schedule and phase II backed by $0.5B in U.S. funding. Commercialization of Silicon-28, Carbon-14, and Ytterbium-176 is expected by H1 2026, while regulatory and commercial milestones support growth in uranium enrichment and electronic gases.
ASP Isotopes to Participate in Canaccord Genuity's 2nd Annual CG Virtual Sustainability Summit
DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the pr...
ASP Isotopes announces Quantum Leap enters MOU with U.S. energy company
ASP Isotopes (ASPI) announced that Quantum Leap Energy has entered into a non-binding Memorandum of Understanding, MOU, with a large publicly traded U.S. energy company that operates nuclear power sta...
Quantum Leap Energy Enters into Memorandum of Understanding with a Large U.S. Energy Company Regarding Evaluation of Support to Advance Domestic Enriched Uranium Fuel Supply Chain
Marks an important step toward enhancing the domestic supply chain for nuclear fuel in the United States Advances QLE's strategy to build U.S.-based capabilities to support advanced nuclear fuel produ...
ASP Isotopes’ Quantum Leap appoints Nate Salpeter as CTO
ASP Isotopes (ASPI) announced that Quantum Leap Energy has appointed Nate Salpeter, Ph.D. as its Chief Technology Officer. Dr. Salpeter was previously the first fluid dynamicist at both TerraPower and...
ASP Isotopes Transcript: Emerging Growth Virtual Conference
ASP Isotopes detailed expansion plans across nuclear medicine, semiconductors, and nuclear fuels, highlighting new contracts, plant upgrades, and a pending spin-off. Regulatory progress and strategic supply chain moves position the company for significant growth in 2024.
ASP Isotopes announces Quantum Leap, Necsa advance collaboration
ASP Isotopes (ASPI) announced that on February 20, 2026, a South African subsidiary of Quantum Leap Energy and the South African Nuclear Energy Corporation, Necsa, executed a Pre-Implementation Servic...